For the second year in a row, the Berlin Conference addresses the AMR market and its challenges with a particular focus on the challenges of small and medium-sized enterprises (SMEs). The one-day event aims at bringing together people from science and business, investors and policy makers, funding bodies and venture capitalists, startups and health economics experts, the public and private sector, to build a discussion platform for all stakeholders.
BIOCOM AG and the BEAM Alliance, representing biopharmaceutical companies from Europe innovating in antimicrobial resistance research, invite to attend the 11th Berlin Conference in Life Sciences – Novel Antimicrobials & AMR Diagnostics.
Place: Fraunhofer-Forum Berlin
Date: 2nd March 2018
The InfectoGnostics Research Campus will present its collaborative research inion 4
Session 4 - Technology highlights and challenges – diagnostics:
- Bringing photonics to the clinic: concept for a user-open center for photonics in infection research
Jürgen Popp, Managing Board, InfectoGnostics Research Campus Jena & Forschungsverbund Leibniz Gesundheitstechnologien, GER - Development of Diagnostics for antimicrobial resistance – a company perspective
Ralf Ehricht, Prinicipal Scientist, Abbott (former Alere Technologies GmbH), GER
More information